These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20362512)

  • 21. Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study.
    Barad DH; Darmon S; Weghofer A; Latham GJ; Filipovic-Sadic ; Wang Q; Kushnir VA; Albertini DF; Gleicher N
    Reprod Biol Endocrinol; 2017 Apr; 15(1):34. PubMed ID: 28454580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing.
    Gleicher N; Weghofer A; Barad DH
    Reprod Biomed Online; 2010 Jun; 20(6):768-75. PubMed ID: 20378415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles.
    La Marca A; Marzotti S; Brozzetti A; Stabile G; Artenisio AC; Bini V; Giordano R; De Bellis A; Volpe A; Falorni A;
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3816-23. PubMed ID: 19622621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of FMR1 repeat size with ovarian dysfunction.
    Sullivan AK; Marcus M; Epstein MP; Allen EG; Anido AE; Paquin JJ; Yadav-Shah M; Sherman SL
    Hum Reprod; 2005 Feb; 20(2):402-12. PubMed ID: 15608041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive decline of residual follicle pool after clinical diagnosis of autoimmune ovarian insufficiency.
    Falorni A; Brozzetti A; Aglietti MC; Esposito R; Minarelli V; Morelli S; Sbroma Tomaro E; Marzotti S
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):453-8. PubMed ID: 22417127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar prevalence of expanded CGG repeat lengths in the fragile X mental retardation I gene among infertile women and among women with proven fertility: a prospective study.
    De Geyter C; M'Rabet N; De Geyter J; Zürcher S; Moffat R; Bösch N; Zhang H; Heinimann K
    Genet Med; 2014 May; 16(5):374-8. PubMed ID: 24113347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of genetic and autoimmune factors in premature ovarian failure.
    Shamilova NN; Marchenko LA; Dolgushina NV; Zaletaev DV; Sukhikh GT
    J Assist Reprod Genet; 2013 Jun; 30(5):617-22. PubMed ID: 23504400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of an age-related correlation of ovarian reserve and FMR1 repeat number among women with "normal" CGG repeat status.
    Gustin SL; Ding VY; Desai M; Leader B; Baker VL
    J Assist Reprod Genet; 2015 Nov; 32(11):1669-76. PubMed ID: 26409477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are follicle stimulating hormone measurements predictive of ovarian response to hyperstimulation with human menopausal gonadotrophin?
    Oghoetuoma J; Polson DW; Troup SA; Lieberman BA
    J Obstet Gynaecol; 1997 Mar; 17(2):188-91. PubMed ID: 15511819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The FMR1 gene as regulator of ovarian recruitment and ovarian reserve.
    Gleicher N; Barad DH
    Obstet Gynecol Surv; 2010 Aug; 65(8):523-30. PubMed ID: 20955631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.
    Soto N; Iñiguez G; López P; Larenas G; Mujica V; Rey RA; Codner E
    Hum Reprod; 2009 Nov; 24(11):2838-44. PubMed ID: 19643804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menstrual cycle length in relation to antimüllerian hormone and follicle-stimulating hormone.
    Rashidi BH; Abediasl Z; Tehraninejad ES; Shariat M; Mahdavi A
    J Reprod Med; 2009 May; 54(5):315-8. PubMed ID: 19517697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of normal-range FMR1 repeat length or genotypes and reproductive parameters.
    Maslow BS; Davis S; Engmann L; Nulsen JC; Benadiva CA
    J Assist Reprod Genet; 2016 Sep; 33(9):1149-55. PubMed ID: 27189053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation.
    Bodega B; Bione S; Dalprà L; Toniolo D; Ornaghi F; Vegetti W; Ginelli E; Marozzi A
    Hum Reprod; 2006 Apr; 21(4):952-7. PubMed ID: 16361284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fresh human orthotopic ovarian cortex transplantation: long-term results.
    Sánchez M; Alamá P; Gadea B; Soares SR; Simón C; Pellicer A
    Hum Reprod; 2007 Mar; 22(3):786-91. PubMed ID: 17110398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.